CONCENTRIX CORP's ticker is CNXC and the CUSIP is 20602D101. A total of 357 filers reported holding CONCENTRIX CORP in Q1 2022. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $95,891 | -4.6% | 1,515 | -0.3% | 0.00% | – |
| Q1 2024 | $100,556 | -32.8% | 1,519 | -0.3% | 0.00% | – |
| Q4 2023 | $149,551 | +24.2% | 1,523 | +1.3% | 0.00% | – |
| Q3 2023 | $120,405 | -1.8% | 1,503 | -1.0% | 0.00% | – |
| Q2 2023 | $122,579 | -33.6% | 1,518 | 0.0% | 0.00% | – |
| Q1 2023 | $184,513 | -8.7% | 1,518 | 0.0% | 0.00% | – |
| Q4 2022 | $202,137 | +14.2% | 1,518 | -3.9% | 0.00% | – |
| Q3 2022 | $177,000 | +149.3% | 1,580 | +201.0% | 0.00% | – |
| Q2 2022 | $71,000 | -15.5% | 525 | +4.4% | 0.00% | – |
| Q1 2022 | $84,000 | -6.7% | 503 | 0.0% | 0.00% | – |
| Q4 2021 | $90,000 | +1.1% | 503 | 0.0% | 0.00% | – |
| Q3 2021 | $89,000 | +9.9% | 503 | 0.0% | 0.00% | – |
| Q2 2021 | $81,000 | +8.0% | 503 | 0.0% | 0.00% | – |
| Q1 2021 | $75,000 | +25.0% | 503 | -16.6% | 0.00% | – |
| Q4 2020 | $60,000 | – | 603 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Groupe Bruxelles Lambert | 8,773,667 | $555,197,648 | 100.00% |
| Impactive Capital LP | 3,846,370 | $243,398,294 | 9.46% |
| PARADIGM CAPITAL MANAGEMENT INC/NY | 623,542 | $39,457,738 | 1.80% |
| LYRICAL ASSET MANAGEMENT LP | 1,271,250 | $80,444,700 | 1.29% |
| Copeland Capital Management, LLC | 985,722 | $62,376,533 | 1.17% |
| Nierenberg Investment Management Company, Inc. | 27,910 | $1,766,145 | 0.99% |
| CAUSEWAY CAPITAL MANAGEMENT LLC | 564,732 | $35,736,207 | 0.97% |
| VALLEY WEALTH MANAGERS, INC. | 168,482 | $10,661,541 | 0.85% |
| Bragg Financial Advisors, Inc | 202,698 | $12,826,730 | 0.57% |
| CLARK ESTATES INC/NY | 44,250 | $2,800,140 | 0.53% |